Coming soon
MELANOMA BRIDGE
December 30th - 2nd, 2023
FACULTY
Sanjiv S. Agarwala
Professor of Hematology & Oncology, Temple University School of Medicine, Philadelphia, PA, US
Ana Arance
Researcher, Clinic Barcelona, Barcelona, Spain
Paolo A. Ascierto
Director of Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy
Allison Betof Warner
Assistant Professor of Medicine (Oncology), Director, Melanoma Medical Oncology Program, Director, Solid Tumor Cellular Therapy Leader, Melanoma & Cutaneous Oncology Clinical Research Group, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA, US
Christian Blank
Medical Oncology and Research Group Leader Tumor Immunology, Netherlands Cancer Institute, Amsterdam; Medical Oncology, Leiden University Medical Center (LUMC), Leiden, Netherlands
Corrado Caracò
Director of Melanoma and Skin Tumor Surgery, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy
Richard D. Carvajal
Director of Experimental Therapeutics, Director of the Melanoma Service, Columbia University Medical Center, New York, NY, US
Michele Del Vecchio
Responsabile S.S. Oncologia Medica Melanomi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Reinhard Dummer
Vice Director, Department of Dermatology; Director, Clinical Trials Comprehensive Cancer Center Zurich (CCCZ), University Hospital Zurich, Zurich, Switzerland
Alexander M.M. Eggermont
Chief Scientific Officer, Board of Directors, Princess Máxima Center; Professor of Clinical & Translational Immunotherapy, Utrecht University, Utrecht, Netherlands
Marc S. Ernstoff
Branch Chief, ImmunoOncology Branch (IOB), Developmental Therapeutics Program, Cancer Therapy & Diagnosis Division, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, US
Laura K. Ferris
Director of Clinical Trials, UPMC Department of Dermatology, UPMC Hillman Cancer Center, University of Pittsburgh, PA, US
Jeffrey E. Gershenwald
Dr. John M. Skibber Endowed Professor of Surgery, Department of Surgical Oncology, Medical Director, Melanoma and Skin Center, The University of Texas, MD Anderson Cancer Center, Distinguished Senior Lecturer, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA
Samantha Guild
President AIM at Melanoma Richmond, CA, US
Omid Hamid
Chief of Research/ Immuno-Oncology, Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, US
Mustafa Khasraw
Professor of Neurosurgery, Professor in Medicine, Member of the Duke Cancer Institute, Durham, NC, USA
Samir N. Khleif
Director of the Center for Immunology and Immunotherapy, Director of The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington, DC, US
Simone Krebs
Assistant Attending Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Michelle Krogsgaard
Associate Professor of Pathology, Co-leader of Tumor Immunology Program, Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, US
Roger S. Lo
Professor of Medicine/Dermatology, Associate Chief of Dermatology, Director of the Dermatology STAR Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, US
Jason J. Luke
Director, Immunotherapy and Drug Development Center, Associate Professor of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, US
Amanda Lund
Associate Professor, Ronald O. Perelman Department of Dermatology, Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY US
Mario Mandalà
Associate Professor of Medical Oncology, University of Perugia, Perugia, Italy
Francesco Marincola
Chief Scientific Officer, Sonata Therapeutics, Watertown, MA, US
Marius E. Mayerhoefer
Member of the Faculty, Department of Radiology, NYU Grossman School of Medicine, New York, NY, US
Janice M. Mehnert
Professor of Medicine, Associate Director for Clinical Research, Laura and Isaac Perlmutter Cancer Center, Director, Melanoma and Cutaneous Medical Oncology, NYU Grossman School of Medicine, New York, NY, US
Olivier Michielin
Full Professor, Chair of Oncology Department and Precision Oncology Service, Geneva University Hospital, Geneva; Co-Director of the Swiss Cancer Center Léman, Agora – Lausanne, Switzerland
Luigi Nezi
Group leader for Microbiome and T Cell Metabolism in Cancer, IEO- istituto Europeo di Oncologia
Milan, Italy
Iman Osman
Professor, Departments of Medicine (Oncology) and Urology, Director, Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support, NYU Grossman School of Medicine, New York, NY, US
Giuseppe Palmieri
Full Professor of Medical Oncology, University of Sassari; Head of Unit of Cancer Genetics, National Research Council (CNR), Sassari, Italy
Anna Pavlick
Director, WCM Melanoma and Cutaneous Oncology Program, Weill Cornell Medical College, New York, New York, US
Claudia Piazza Cidonio
Co-Founder, Melanoma Italia Onlus, Rome, Italy
Michael A. Postow
Chief, Melanoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, US
Poulikos I. Poulikakos
Professor, Department of Oncological Sciences, Precision Immunology Institute, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York NY, US
Igor Puzanov
Senior Vice President, Clinical Investigation; Professor of Oncology and Medicine, Director of Center for Early Phase Clinical Trials Division, Chief, Melanoma Section, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US
Dirk Schadendorf
Director of the Department of Dermatology, University Hospital Essen, Essen, Germany
Mayra Shanley
Principal Research Scientist, Stem Cell Transplantation Department, MD Anderson Cancer Center, Houston, Texas, US
Alexander Shoushtari
Clinical Director, Melanoma Service; Member, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
James Smithy
Assistant Attending Physician Melanoma & Cellular Therapy Services
Memorial Sloan Kettering Cancer Center, New York, NY, US
Jeffrey A. Sosman
Professor of Medicine, Director, Melanoma program, Director, Faculty Development, Co-Leader, Translational Research in Solid Tumors, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, US
Ryan J. Sullivan
Associate Professor of Medicine, Harvard Medical School; Associate Professor of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, US
Hussein A. Tawbi
Deputy Chair and Director of Personalized Cancer Therapy, Department of Melanoma Medical Oncology, Division of Cancer Medicine, Co-Director, MD Anderson Brain Metastasis Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, US
Alessandro Testori
Chairman surgical subgroup, EORTC Melanoma Group, Brussels, Belgium
Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, US
Thach-Giao Truong
Melanoma Program Medical Director, Cleveland Clinic, Cleveland, OH, US
Lisa Villabona
Affiliated to research, Department of Oncology-Pathology, Karolinska Institutet, Cancer Centrum Karolinska (CCK), Karolinska University Hospital, Stockholm, Sweden
Jeffrey S. Weber
Deputy Director, Laura and Isaac Perlmutter Cancer Center, Professor of Oncology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, US